Article
Front-line liquid biopsy for early molecular assessment and treatment of hospitalized lung cancer patients.
Cancer treatment and research communications - 1 Jan 2024
Parisi Francesca, De Luca Giuseppa, Mosconi Manuela, Lastraioli Sonia, Dellepiane Chiara, Rossi Giovanni, Puglisi Silvia, Bennicelli Elisa, Barletta Giulia, Zullo Lodovica, Santamaria Sara, Mora Marco, Ballestrero Alberto, Montecucco Fabrizio, Bellodi Andrea, Del Mastro Lucia, Lambertini Matteo, Barisione Emanuela, Cittadini Giuseppe, Tagliabue Elena, Spagnolo Francesco, Tagliamento Marco, Coco Simona, Dono Mariella, Genova Carlo
Abstract excerpt
BACKGROUND: Molecular characterization is pivotal for managing non-small cell lung cancer (NSCLC), although this process is often time-consuming and patients' conditions might worsen while molecular analyses are processed. Our primary aim was to evaluate the performance of "up-front" next-generation sequencing (NGS) through liquid biopsy (LB) of hospitalized patients with newly detected lung neoplasm in parallel...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.